Radiofrequency ablation of neuroendocrine liver metastases.
Elvin
A
A
Department of Radiology, Karolinska Hospital, S-171 76 Stockholm, Sweden. anders.elvin@bostream.nu
Skogseid
B
B
Hellman
P
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D002276:Carcinoid Tumor / Q000556:secondary / Q000601:surgery; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000145:classification / Q000556:secondary* / Q000601:surgery; D046790:Pancreas, Exocrine / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000473:pathology; D010347:Patient Care Planning; D011183:Postoperative Complications; D015641:Radiography, Interventional; D014057:Tomography, X-Ray Computed; D018608:Ultrasonography, Doppler; D018084:Ultrasonography, Interventional
D014408:Biomarkers, Tumor; D053379:Chromogranin A; D002864:Chromogranins